Loading
This page follows insider dealings at NeonMind Biosciences Inc. as filed with SEDI. The past year has been quiet: not a single insider filing for NeonMind Biosciences Inc. The previous disclosure was published on 30 January 2023.
Since 2020, the database holds 24 purchases and 12 sales by insiders of the company.
Source: insider filings from SEDI. Past trades are no guide to future returns.
25 of 79 declarations
NeonMind Biosciences Inc. is a company focused on the research and development of psychedelic treatments for mental health disorders. It is listed on the Toronto Stock Exchange under the symbol XTSE.